SynthesisJournal of managed care & specialty pharmacy2015

Emergence of BCR-ABL kinase domain mutations associated with newly diagnosed chronic myeloid leukemia: a meta-analysis of clinical trials of tyrosine kinase inhibitors.

Iulia D Ursan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.